The Irish Wolfhound Foundation

Clinical and Immunological Outcomes in Dogs with Osteosarcoma Treated with Intratumoral Interleukin-12 Microspheres

Study End Date: Ongoing
Enrollment Status: CLOSED to new enrollment
Lead Researcher(s): Dr. Stuart Helfand

Dogs who undergo amputation and chemotherapy often have extended lives but 99% of these dogs develop metastatic disease. This study investigates a novel way to possibly delay the onset of metastatic disease. The Irish Wolfhound Foundation has pledged $3000 in financial support for this study. This study will involve all breeds and is sponsored by the Canine Health Foundation.

Dr. Stuart Helfand from the University of Wisconsin Veterinary Teaching Hospital is the principal investigator.

An OffLead Production powered by Dialogs